- Home
- DLPN vs CRIS Comparison
DLPN vs CRIS Comparison
Compare DLPN & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLPN
- CRIS
- Stock Information
- Founded
- DLPN 1996
- CRIS 2000
- Country
- DLPN United States
- CRIS United States
- Employees
- DLPN N/A
- CRIS N/A
- Industry
- DLPN Other Consumer Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DLPN Consumer Discretionary
- CRIS Health Care
- Exchange
- DLPN Nasdaq
- CRIS Nasdaq
- Market Cap
- DLPN 21.8M
- CRIS 18.6M
- IPO Year
- DLPN N/A
- CRIS 2000
- Fundamental
- Price
- DLPN $1.59
- CRIS $1.25
- Analyst Decision
- DLPN Strong Buy
- CRIS Strong Buy
- Analyst Count
- DLPN 1
- CRIS 2
- Target Price
- DLPN $5.00
- CRIS $16.50
- AVG Volume (30 Days)
- DLPN 42.7K
- CRIS 75.7K
- Earning Date
- DLPN 11-12-2025
- CRIS 11-06-2025
- Dividend Yield
- DLPN N/A
- CRIS N/A
- EPS Growth
- DLPN N/A
- CRIS N/A
- EPS
- DLPN N/A
- CRIS N/A
- Revenue
- DLPN $51,257,243.00
- CRIS $11,650,000.00
- Revenue This Year
- DLPN $9.05
- CRIS $2.72
- Revenue Next Year
- DLPN $15.42
- CRIS $8.27
- P/E Ratio
- DLPN N/A
- CRIS N/A
- Revenue Growth
- DLPN 4.84
- CRIS 13.56
- 52 Week Low
- DLPN $0.75
- CRIS $1.02
- 52 Week High
- DLPN $1.88
- CRIS $4.70
- Technical
- Relative Strength Index (RSI)
- DLPN 49.69
- CRIS 24.41
- Support Level
- DLPN $1.43
- CRIS $1.21
- Resistance Level
- DLPN $1.79
- CRIS $1.49
- Average True Range (ATR)
- DLPN 0.14
- CRIS 0.08
- MACD
- DLPN -0.03
- CRIS -0.02
- Stochastic Oscillator
- DLPN 29.78
- CRIS 6.38
About DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.